Copyright Reports & Markets. All rights reserved.

Global Gene Therapy for Inherited Genetic Disorders Market Opportunities and Forecast 2022-2028

Request for Sample of this report
Buy now

Table of Contents

    1 Product Introduction and Overview

    • 1.1 Product Definition
    • 1.2 Product Specification
    • 1.3 Global Market Overview
      • 1.3.1 Global Gene Therapy for Inherited Genetic Disorders Market Status and Forecast (2017-2028)
      • 1.3.2 Global Gene Therapy for Inherited Genetic Disorders Sales Value CAGR by Region
    • 1.4 Market Drivers, Inhibitors
      • 1.4.1 Market Drivers
      • 1.4.2 Market Inhibitors
      • 1.4.3 COVID-19 Impact Analysis

    2 Global Gene Therapy for Inherited Genetic Disorders Supply by Company

    • 2.1 Global Gene Therapy for Inherited Genetic Disorders Sales Value by Company
    • 2.2 Gene Therapy for Inherited Genetic Disorders Sales Area of Main Manufacturers
    • 2.3 Trend of Concentration Rate

    3 Global and Regional Gene Therapy for Inherited Genetic Disorders Market Status by Type

    • 3.1 Gene Therapy for Inherited Genetic Disorders Type Introduction
      • 3.1.1 Eye Disorders
      • 3.1.2 Hematological Disorders
      • 3.1.3 Central Nervous System Disorders
      • 3.1.4 Muscular Disorders
      • 3.1.5 Others
    • 3.2 Global Gene Therapy for Inherited Genetic Disorders Market by Type
    • 3.3 North America: by Type
    • 3.4 Europe: by Type
    • 3.5 Asia Pacific: by Type
    • 3.6 Central & South America: by Type
    • 3.7 Middle East & Africa: by Type

    4 Global and Regional Gene Therapy for Inherited Genetic Disorders Market Status by Application

    • 4.1 Gene Therapy for Inherited Genetic Disorders Segment by Application
      • 4.1.1 Hospital
      • 4.1.2 Clinic
      • 4.1.3 Research Institute
      • 4.1.4 Others
    • 4.2 Global Gene Therapy for Inherited Genetic Disorders Market by Application
    • 4.3 North America: by Application
    • 4.4 Europe: by Application
    • 4.5 Asia Pacific: by Application
    • 4.6 Central & South America: by Application
    • 4.7 Middle East & Africa: by Application

    5 Global Gene Therapy for Inherited Genetic Disorders Market Status by Region

    • 5.1 Global Gene Therapy for Inherited Genetic Disorders Market by Region
    • 5.2 North America Gene Therapy for Inherited Genetic Disorders Market Status
    • 5.3 Europe Gene Therapy for Inherited Genetic Disorders Market Status
    • 5.4 Asia Pacific Gene Therapy for Inherited Genetic Disorders Market Status
    • 5.5 Central & South America Gene Therapy for Inherited Genetic Disorders Market Status
    • 5.6 Middle East & Africa Gene Therapy for Inherited Genetic Disorders Market Status

    6 North America Gene Therapy for Inherited Genetic Disorders Market Status

    • 6.1 North America Gene Therapy for Inherited Genetic Disorders Market by Country
    • 6.2 United States
    • 6.3 Canada
    • 6.4 Mexico

    7 Europe Gene Therapy for Inherited Genetic Disorders Market Status

    • 7.1 Europe Gene Therapy for Inherited Genetic Disorders Market by Country
    • 7.2 Germany
    • 7.3 France
    • 7.4 UK
    • 7.5 Italy
    • 7.6 Russia
    • 7.7 Spain

    8 Asia Pacific Gene Therapy for Inherited Genetic Disorders Market Status

    • 8.1 Asia Pacific Gene Therapy for Inherited Genetic Disorders Market by Country
    • 8.2 China
    • 8.3 Japan
    • 8.4 Korea
    • 8.5 Southeast Asia
    • 8.6 India
    • 8.7 Australasia

    9 Central & South America Gene Therapy for Inherited Genetic Disorders Market Status

    • 9.1 Central & South America Gene Therapy for Inherited Genetic Disorders Market by Country
    • 9.2 Brazil
    • 9.3 Argentina
    • 9.4 Colombia

    10 Middle East & Africa Gene Therapy for Inherited Genetic Disorders Market Status

    • 10.1 Middle East & Africa Gene Therapy for Inherited Genetic Disorders Market by Country
    • 10.2 Iran
    • 10.3 Israel
    • 10.4 Turkey
    • 10.5 South Africa
    • 10.8 Saudi Arabia

    11 Major Downstream Customers Analysis

    • 11.1 Customer One Analysis
    • 11.2 Customer Two Analysis
    • 11.3 Customer Three Analysis
    • 11.4 Customer Four Analysis

    12 Global Gene Therapy for Inherited Genetic Disorders Market Forecast by Type and by Application

    • 12.1 Global Gene Therapy for Inherited Genetic Disorders Sales Value Forecast (2023-2028)
    • 12.2 Global Gene Therapy for Inherited Genetic Disorders Forecast by Type
    • 12.3 Global Gene Therapy for Inherited Genetic Disorders Forecast by Application

    13 Global Gene Therapy for Inherited Genetic Disorders Market Forecast by Region/Country

    • 13.1 Global Gene Therapy for Inherited Genetic Disorders Market Forecast by Region (2023-2028)
    • 13.2 North America Market Forecast
    • 13.3 Europe Market Forecast
    • 13.4 Asia Pacific Market Forecast
    • 13.5 Central & South America Market Forecast
    • 13.6 Middle East & Africa Market Forecast

    14 Key Participants Company Information

    • 14.1 Spark Therapeutics Inc.
      • 14.1.1 Company Information
      • 14.1.2 Gene Therapy for Inherited Genetic Disorders Product Introduction
      • 14.1.3 Spark Therapeutics Inc. Gene Therapy for Inherited Genetic Disorders Sales Value, Gross Margin and Global Share (2020-2022)
      • 14.1.4 SWOT Analysis
    • 14.2 Orchard Therapeutics Plc
      • 14.2.1 Company Information
      • 14.2.2 Gene Therapy for Inherited Genetic Disorders Product Introduction
      • 14.2.3 Orchard Therapeutics Plc Gene Therapy for Inherited Genetic Disorders Sales Value, Gross Margin and Global Share (2020-2022)
      • 14.2.4 SWOT Analysis
    • 14.3 Novartis AG
      • 14.3.1 Company Information
      • 14.3.2 Gene Therapy for Inherited Genetic Disorders Product Introduction
      • 14.3.3 Novartis AG Gene Therapy for Inherited Genetic Disorders Sales Value, Gross Margin and Global Share (2020-2022)
      • 14.3.4 SWOT Analysis
    • 14.4 bluebird bio Inc.
      • 14.4.1 Company Information
      • 14.4.2 Gene Therapy for Inherited Genetic Disorders Product Introduction
      • 14.4.3 bluebird bio Inc. Gene Therapy for Inherited Genetic Disorders Sales Value, Gross Margin and Global Share (2020-2022)
      • 14.4.4 SWOT Analysis
    • 14.5 BioMarin Pharmaceutical Inc.
      • 14.5.1 Company Information
      • 14.5.2 Gene Therapy for Inherited Genetic Disorders Product Introduction
      • 14.5.3 BioMarin Pharmaceutical Inc. Gene Therapy for Inherited Genetic Disorders Sales Value, Gross Margin and Global Share (2020-2022)
      • 14.5.4 SWOT Analysis

    ...

      15 Conclusion

        16 Methodology

        This report provides a comprehensive analysis of current global Gene Therapy for Inherited Genetic Disorders market based on segmented types and downstream applications. Major product development trends are discussed under major downstream segment scenario.This report also focuses on major driving factors and inhibitors that affect the market and competitive landscape. Global and regional leading players in the Gene Therapy for Inherited Genetic Disorders industry are profiled in a detailed way, with sales data and market share info. This report also includes global and regional market size and forecast, drill-down to top 20 economies.

        According to this survey, the global Gene Therapy for Inherited Genetic Disorders market is estimated at $ million in 2021, and projected to grow at a CAGR of % to $ million by 2028.

        Covid-19 pandemic has impacted the supply and demand status for many industries along the supply chain. Global Gene Therapy for Inherited Genetic Disorders Market Opportunities and Forecast 2023-2028 report makes a brilliant attempt to unveil key opportunities available in the global Gene Therapy for Inherited Genetic Disorders market under the Covid-19 impact to help readers in achieving a better market position. No matter the client is industry insider, potential entrant or investor, the report will provide useful data and information.

        The Global Gene Therapy for Inherited Genetic Disorders Market has been exhibited in detail in the following chapters
        Chapter 1 displays the basic product introduction and market overview.
        Chapter 2 provides the competition landscape of global Gene Therapy for Inherited Genetic Disorders industry.
        Chapter 3 provides the market analysis by type and by region
        Chapter 4 provides the market analysis by application and by region
        Chapter 5-10 presents regional and country market size and forecast, under the context of market drivers and inhibitors analysis.
        Chapter 11 analyses the supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis.
        Chapter 12 provides the market forecast by type and by application
        Chapter 13 provides the market forecast by region
        Chapter 14 profies global leading players with their revenue, market share, profit margin, major product portfolio and SWOT analysis.
        Chapter 15 conclusions

        Segmented by Type
        Eye Disorders
        Hematological Disorders
        Central Nervous System Disorders
        Muscular Disorders
        Others

        Segmented by Application
        Hospital
        Clinic
        Research Institute
        Others

        Segmented by Country
        North America
        United States
        Canada
        Mexico
        Europe
        Germany
        France
        UK
        Italy
        Russia
        Spain
        Asia Pacific
        China
        Japan
        Korea
        Southeast Asia
        India
        Australasia
        Central & South America
        Brazil
        Argentina
        Colombia
        Middle East & Africa
        Iran
        Israel
        Turkey
        South Africa
        Saudi Arabia

        Key manufacturers included in this survey
        Spark Therapeutics Inc.
        Orchard Therapeutics Plc
        Novartis AG
        bluebird bio Inc.
        BioMarin Pharmaceutical Inc.
        Buy now